Internal Medicine Alert – October 30, 2012

October 30, 2012

• Some Antihypertensives May Raise Lip Cancer Risk

  Several commonly used photosensitizing antihypertensive drugs can confer as much as a four-fold increase in the risk of lip cancer when prescribed long-term in non-Hispanic whites.

  Read more

• Updating the 2000 Published Guidelines for Preventing Episodic Migraine: Is Anyone Listening?

  This paper updates the American Headache Society and American Academy of Neurology guidelines for prevention of episodic migraine that were previously published in 2000.

  Read more

• Spice and Sugar: Curcumin and Type 2 DM

  Results of this year-long intervention trial suggest that an ethanolic extract of curcumin could, together with appropriate dietary and lifestyle changes, play a role in slowing the progression from prediabetes to type 2 diabetes.

  Read more

• Pharmacology Update: Teriflunomide Tablets (Aubagio®)

  The FDA has approved a second oral drug for the treatment of multiple sclerosis (MS). Teriflunomide, a metabolite of leflunomide and a pyrimidine synthesis inhibitor, is an immunomodulatory agent. It is marketed by Sanofi Aventis as Aubagio.

  Read more

• Clinical Briefs By Louis Kuritzky, MD

  Attenuated CV Benefits of Clopidogrel in Diabetes; Is A1c Always the Best Game in Town to Monitor Type 2 Diabetes?

  Read more